Uploaded February 2026 | Updated September 2026, 2 weeks ago

---

At Davos 2026, Bill Fitzgerald (VP of Growth & Ecosystems at SandboxAQ) speaks with Jesus Mantas, former IBM Consulting leader and biotech board member, about the convergence of AI and biology.

The discussion explores:
• How neural networks are transforming drug discovery
• Designing antibodies using AI
• Cell perturbation models and biological prediction
• Accelerating precision medicine
• Compressing regulatory timelines with AI
• Why data quality, not AI, is often the true bottleneck

As compute scales exponentially and models improve, AI may fundamentally reshape how medicines are discovered, validated, and delivered to patients.

Check out our Voices of Davos playlist for more exclusive interviews like this! youtube.com/playlist?list=PLMsyYLfyvI2H0E5dNwlP0qoI4s8Z8gdMK

Subscribe to stay updated on the latest breakthroughs in AI and quantum technology. Learn more about SandboxAQ’s innovative solutions at: sandboxaq.com

#sandboxaq #lqms